These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34102584)

  • 1. Highly transmitted M. tuberculosis strains are more likely to evolve MDR/XDR and cause outbreaks, but what makes them highly transmitted?
    Alame Emane AK; Guo X; Takiff HE; Liu S
    Tuberculosis (Edinb); 2021 Jul; 129():102092. PubMed ID: 34102584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis.
    Alame Emane AK; Guo X; Takiff HE; Liu S
    Tuberculosis (Edinb); 2021 Jul; 129():102091. PubMed ID: 34090078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Leechawengwongs M; Prammananan T; Jaitrong S; Billamas P; Makhao N; Thamnongdee N; Thanormchat A; Phurattanakornkul A; Rattanarangsee S; Ratanajaraya C; Disratthakit A; Chaiprasert A
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance and characterization of drug-resistant
    Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
    Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand.
    Disratthakit A; Meada S; Prammananan T; Thaipisuttikul I; Doi N; Chaiprasert A
    Infect Genet Evol; 2015 Jun; 32():432-9. PubMed ID: 25847698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
    J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].
    Iwamoto T
    Kekkaku; 2009 Dec; 84(12):755-9. PubMed ID: 20077859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.
    Motiwala AS; Dai Y; Jones-López EC; Hwang SH; Lee JS; Cho SN; Via LE; Barry CE; Alland D
    J Infect Dis; 2010 Mar; 201(6):881-8. PubMed ID: 20136412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant
    Ghajavand H; Kargarpour Kamakoli M; Khanipour S; Pourazar Dizaji S; Masoumi M; Rahimi Jamnani F; Fateh A; Yaseri M; Siadat SD; Vaziri F
    Antimicrob Resist Infect Control; 2019; 8():70. PubMed ID: 31073401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.